|
|
V2017/CTD2098/053
|
NILZOL GOLD
|
LEVAMISOLE HYDROCHLORIDE B.P 3.0%W/V ; OXYCLOZANIDE B.P 6.0%W/V COBALT SULPHATE 0.764%W/V
|
SPHINX PHARMACEUTICALS
|
Registered
|
Details →
|
|
|
H2017/CTD4634/231
|
ENTAMAXIN SUSPENSION
|
DILOXANDE FUROATE B.P. 250 MG, METRONIDAZOLE BENZOATE B.P EQUIVALENT TO METRONIDAZOLE 200 MG DICYCLOMINE HYDRCHLORIDE B.P. 10 MG
|
SPHINX PHARMACEUTICALS
|
Registered
|
Details →
|
|
|
17821
|
ALIMOX DRY SYRUP
|
AMOXYCILLIN TRIHYDRATE B.P. EQUVALENT TO AMOXYCILLIN
|
SPHINX PHARMACEUTICALS
|
Registered
|
Details →
|
|
|
V2017/CTD2097/054
|
NILZOL LIQUID
|
LEVAMISOLE HYDROCHLORIDE B.P 1.5% W/V
|
SPHINX PHARMACEUTICALS
|
Registered
|
Details →
|
|
|
V2017/CTD2101/055
|
HELTIVET
|
OXYTETRACYCLINE HYDROCHLORIDE B.P VET 5.5%W/W
|
SPHINX PHARMACEUTICALS
|
Registered
|
Details →
|
|
|
H2017/CTD4635/235
|
ENTAMAXIN CAPSULES
|
250 MG OF DILOXANIDE FUROATE B.P; 200MG OF METRONIDAZOLE B.P, 10MG OF DICYCLOMINE HYDROCHLORIDE B.P
|
SPHINX PHARMACEUTICALS
|
Registered
|
Details →
|
|
|
V2017/CTD2100/052
|
NILZOL PLUS
|
LEVAMISOLE HYDROCHLORIDE B.P 1.5%W/W AND OXYCLOZANIDE B.P 3.0%W/W
|
SPHINX PHARMACEUTICALS
|
Registered
|
Details →
|
|
|
V2017/CTD2099/051
|
FLUKAN 2.5%
|
ALBENDAZOLE USP 2.5%W/V
|
SPHINX PHARMACEUTICALS
|
Registered
|
Details →
|
|
|
22908
|
NEUROVEN CAPSULES
|
VITAMIN B1 B.P VITAMIN B6 B.P , VITAMINB12 B.P
|
SPHINX PHARMACEUTICALS
|
Registered
|
Details →
|